Tang Capital Management’s Genmab GMAB Stock Holding History

Tang Capital Management’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-200,000	Closed	-$6.13M	–	122
2025 Q3	$6.13M	Hold	200,000	–	–	0.24%	88
2025 Q2	$4.13M	Hold	200,000	–	–	0.21%	91
2025 Q1	$3.92M	Buy	200,000 +100,000	+100%	+$2.1M	0.22%	85
2024 Q4	$2.09M	Hold	100,000	–	–	0.14%	103
2024 Q3	$2.44M	Hold	100,000	–	–	0.17%	94
2024 Q2	$2.51M	Hold	100,000	–	–	0.26%	73
2024 Q1	$2.99M	Buy	+100,000	New	+$2.94M	0.31%	70

Other funds holding GMAB

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Tang Capital Management's GMAB Position: Q4 2025 in Review

Tang Capital Management sold out of Genmab (GMAB) in Q4 2025, closing a stake of 200,000 shares — an estimated $6.13M sold.

Tang Capital Management first reported a position in GMAB in Q1 2024 and held it in 7 quarters. The position peaked at $6.13M in Q3 2025. 292 funds tracked by Wall St. Rank hold GMAB as of Q4 2025.

Tang Capital Management reported no remaining Genmab position as of Q4 2025 after selling out during the quarter.
Tang Capital Management sold 200,000 Genmab shares in Q4 2025, an estimated $6.13M.
Tang Capital Management first reported a position in Genmab in Q1 2024 and held it in 7 quarters.
Tang Capital Management's Genmab position peaked at $6.13M in Q3 2025.
292 funds tracked by Wall St. Rank held Genmab as of Q4 2025.

Based on Tang Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.